Crystal/cell interaction and nephrolithiasis

Archivio Italiano di Urologia e Andrologia

Volumn 83, Issue 1, 2011, Pages 1-5

  Khan, Saeed R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium oxalate; Cells; Crystals; Inflammation; Urinary calculi

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALKALINE PHOSPHATASE; AMMONIUM OXALATE; CALCIUM OXALATE; CALCIUM PHOSPHATE; CARBOXYLIC ACID SALT; ETHYLENE GLYCOL; GAMMA GLUTAMYLTRANSFERASE; MALONALDEHYDE; N ACETYL BETA GLUCOSAMINIDASE; OSTEOPONTIN; OXALATE SODIUM; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

CELL DAMAGE; CELL INTERACTION; CELL PROLIFERATION; CONFERENCE PAPER; CRYSTAL; CRYSTALLIZATION; HUMAN; INFLAMMATION; KIDNEY BIOPSY; KIDNEY INJURY; NEPHROLITHIASIS; NONHUMAN; OXIDATIVE STRESS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ULCER; URINARY EXCRETION; URINE LEVEL; URINE VOLUME; UROLITHIASIS;

ANIMALS; CALCIUM OXALATE; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; KIDNEY; NEPHROLITHIASIS;

EID: 79956099853     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Khan SR, Hackett RL. Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. J Urol 1993; 150:239.
2. Randall A. The Origin and Growth of Renal Calculi. Ann Surg 1937; 105:1009.
3. Low RK, Stoller ML, Schreiber CK. Metabolic and urinary risk factors associated with Randall's papillary plaques. J Endourol 2000; 14:507.
4. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 2009.
5. Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 2004; 9:1450.
6. Robertson WG, Peacock M, Nordin BE. Activity products in stone-forming and non-stone-forming urine. Clin Sci 1968; 34:579.
7. Finlayson B, Reid F. The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978; 15:442.
8. Khan SR. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995; 23:71.
9. Khan SR. Interactions between stone-forming calcific crystals and macromolecules. Urol Int 1997; 59:59.
10. Khan SR. Role of renal epithelial cells in (he initiation of calcium oxalate stones. Nephron Exp Nephrol 2004; 98:e55.
11. Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 2004; 8:75.
12. Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 2005; 33:349.
13. Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 2006; 34:86.
14. Khan SR, Glenton PA, Byer KJ. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 2006; 70:914.
15. Khan SR, Thamilselvan S. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 2000; 4:305.
16. Baggio B, Gambaro G, Ossi E, et al. Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 1983; 129:1161.
17. Boonla C, Wunsuwan R, Tungsanga K, et al. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 2007; 35:185.
18. Tsao KC, Wu TL, Chang PY, et al. Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 2007; 21:426.
19. Thamilselvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 2005; 96:117.
20. Huang HS, Chen J, Chen CF, et al. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 2006; 70:699.
21. Li CY, Deng YL, Sun BH. Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis. Urol Res 2009; 37:211.
22. Tsujihata M, Momohara C, Yoshioka I, et al. Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 2008; 180:2212.
23. Gaspar S, Niculite C, Cucu D, et al. Effect of calcium oxalate on renal cells as revealed by real-time measurement of extracellular oxidative burst. Biosens Bioelectron 25:1729.